Skip to content

Effects of Shrinker Use on Healing and Volume

Effects of Shrinker Use on Healing and Volume for Transtibial Amputees

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00693628
Enrollment
4
Registered
2008-06-09
Start date
2007-03-31
Completion date
2012-01-31
Last updated
2017-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transtibial Amputation

Keywords

volume, healing, shrinker, transtibial amputation, individuals who have undergone transtibial amputation

Brief summary

We expect subjects in the interventional groups, who wear shrinkers, to heal more quickly than control subjects who wear no shrinkers. We also expect them to experience greater reduction in residual limb volume during the early stages of postoperative care leading up to prosthetic fitting, fewer healing complications, reduced time to the prosthetic fitting, increased time to the first prosthetic socket replacement, and fewer socket replacements by the end of the transition to stable phase.

Detailed description

Edema is an inevitable result of amputation surgery. Persistent edema can affect oxygen and nutrient flow into, as well as waste flow out of the residual limb. Shrinkers are a common and effective treatment for edema. However, their influence on healing and long term limb volume has not been studied. This study will pertain to human subjects affected by primary transtibial amputation. Two interventional groups of patients will use shrinkers with different levels of compression as part of their rehabilitation. A third, control group will not use shrinkers. The groups will be studied to determine the effects of shrinker use on healing and long term residual limb volume.

Interventions

DEVICEcompression shrinker

Two levels of compression: 20-30 mmHg or 30-40 mmHg shrinker

Sponsors

University of Oklahoma
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Recently undergone primary transtibial amputation * Patients between ages of 18 and 100 years of age

Exclusion criteria

* Undergone previous amputations above the Symes level

Design outcomes

Primary

MeasureTime frameDescription
Reduction in Time to Healing1 yeartime to healing in each group

Countries

United States

Participant flow

Participants by arm

ArmCount
Shrinker
Patients receive 20-30 mmHg or 30-40 mmHg shrinker, an elastic compression garment that is worn on the residual limb and is used to reduce edema and promote healing. compression shrinker: Two levels of compression: 20-30 mmHg or 30-40 mmHg shrinker
0
No Shrinker
Patients will receive no shrinker
0
Total0

Baseline characteristics

CharacteristicTotal
Age, Categorical
<=18 years
0
Age, Categorical
>=65 years
0
Age, Categorical
Between 18 and 65 years
0
Region of Enrollment
United States
— participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Reduction in Time to Healing

time to healing in each group

Time frame: 1 year

Population: study was closed due to low enrollment. Data were not collected.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026